AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

While Budget 2025 is expected to bring refinements that could further elevate certain industries, a critical shift in the ...

Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, expectations were $1.74. Operator: Hello, and welcome to the Second Quarter ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

Pharma, biopharma, and medical device makers should watch out for these perennial problems, which include inadequate ...

In 2024, AI was one of the hottest topics, affecting every corner of nearly every industry. It has continued to become deeply ...

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 20,809.88 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Quality control processes can have a reputation for being redundant or tedious, but they play a fundamental role in producing ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...